Stock Fundamentals

AMGN.US Logo

AMGN.US - Current Price

$337.54

Company Information

▼
Company Name
Amgen Inc
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NASDAQ
ISIN: US0311621009
CIK: 0000318154
CUSIP: 031162100
Currency: USD
Full Time Employees: 28,000
Phone: 805 447 1000
Website: https://www.amgen.com
Fiscal Year End: December
IPO Date: Jun 17, 1983
Description:

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Address:

One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799

Directors & Officers

▼
Name Title Year Born
Mr. Robert A. Bradway Chairman, CEO & President 1963
Mr. Peter H. Griffith Executive VP & CFO 1959
Dr. David M. Reese M.D. Executive VP & CTO 1963
Mr. Murdo Gordon Executive Vice President of Global Commercial Operations 1967
Dr. James E. Bradner M.D. Executive Vice President of Research & Development 1972
Mr. Esteban Santos Executive Vice President of Operations 1968
Mr. Matthew C. Busch Chief Accounting Officer & VP of Finance 1975
Mr. Scott Skellenger Senior VP & Chief Information Officer NA
Mr. Howard Y. Chang M.D., Ph.D. Senior VP of Global Research & Chief Scientific Officer NA
Casey Capparelli Executive Director of Investor Relations NA

Shares Statistics

▼
Shares Outstanding: 538.48M
Shares Float: 537.12M
% Insiders: 21.20%
% Institutions: 8,384.50%
Short % Float: 2.50%

Valuation Metrics

▼
Enterprise Value: $226.11B
Trailing P/E: 26.11
Forward P/E: 15.27

Financial Highlights

▼
Market Cap: $181.76B
EBITDA: $16.48B
P/E Ratio: $26.11
PEG Ratio: $1.06
Book Value: $17.86
Dividend/Share: $9.39
Dividend Yield: 2.81%
Earnings/Share: $12.93
Profit Margin: 19.47%
Operating Margin: 34.15%
ROA (TTM): 7.71%
ROE (TTM): 81.71%
Revenue (TTM): $35.97B
Revenue/Share (TTM): $66.89
Earnings Growth (YOY): 13.60%
Revenue Growth (YOY): 12.40%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Mar 31, 2026 N/A N/A N/A N/A
Dec 31, 2025 N/A N/A N/A N/A
Sep 30, 2025 5.64 5.02 N/A 1,235.06%
Jun 30, 2025 6.02 5.28 N/A 1,401.52%
Mar 31, 2025 4.90 4.26 N/A 1,502.35%
Dec 31, 2024 5.31 5.08 N/A 452.76%
Sep 30, 2024 5.58 5.11 N/A 919.77%
Jun 30, 2024 4.97 5.01 N/A -79.84%
Mar 31, 2024 3.96 3.87 N/A 232.56%
Dec 31, 2023 4.71 4.61 N/A 216.92%
Sep 30, 2023 4.96 4.67 N/A 620.99%
Jun 30, 2023 5.00 4.49 N/A 1,135.86%
Mar 31, 2023 3.98 3.85 N/A 337.66%
Dec 31, 2022 4.09 4.10 N/A -24.39%
Sep 30, 2022 4.70 4.44 N/A 585.59%
Jun 30, 2022 4.65 4.40 N/A 568.18%
Mar 31, 2022 4.25 4.09 N/A 391.20%
Dec 31, 2021 4.36 4.08 N/A 686.27%
Sep 30, 2021 4.67 4.27 N/A 936.77%
Jun 30, 2021 4.38 4.09 N/A 709.05%
Mar 31, 2021 3.70 4.05 N/A -864.20%
Dec 31, 2020 3.81 3.39 N/A 1,238.94%
Sep 30, 2020 4.37 3.81 N/A 1,469.82%
Jun 30, 2020 4.25 3.82 N/A 1,125.65%
Mar 31, 2020 4.17 3.76 N/A 1,090.43%
Dec 31, 2019 3.64 3.47 N/A 489.91%
Sep 30, 2019 3.66 3.53 N/A 368.27%
Jun 30, 2019 3.97 3.59 N/A 1,058.50%
Mar 31, 2019 3.56 3.48 N/A 229.89%
Dec 31, 2018 3.42 3.27 N/A 458.72%
Sep 30, 2018 3.69 3.45 N/A 695.65%
Jun 30, 2018 3.83 3.54 N/A 819.21%
Mar 31, 2018 3.47 3.23 N/A 743.03%
Dec 31, 2017 2.89 3.03 N/A -462.05%
Sep 30, 2017 3.27 3.11 N/A 514.47%
Jun 30, 2017 3.27 3.11 N/A 514.47%
Mar 31, 2017 3.15 3.00 N/A 500.00%
Dec 31, 2016 2.89 2.79 N/A 358.42%
Sep 30, 2016 3.02 2.79 N/A 824.37%
Jun 30, 2016 2.84 2.74 N/A 364.96%
Mar 31, 2016 2.90 2.60 N/A 1,153.85%
Dec 31, 2015 2.61 2.29 N/A 1,397.38%
Sep 30, 2015 2.72 2.38 N/A 1,428.57%
Jun 30, 2015 2.57 2.43 N/A 576.13%
Mar 31, 2015 2.48 2.10 N/A 1,809.52%
Dec 31, 2014 2.16 2.05 N/A 536.59%
Sep 30, 2014 2.30 2.11 N/A 900.47%
Jun 30, 2014 2.37 2.07 N/A 1,449.28%
Mar 31, 2014 1.87 1.94 N/A -360.82%
Dec 31, 2013 1.82 1.68 N/A 833.33%
Sep 30, 2013 1.94 1.77 N/A 960.45%
Jun 30, 2013 1.89 1.74 N/A 862.07%
Mar 31, 2013 1.96 1.84 N/A 652.17%
Dec 31, 2012 1.40 1.38 N/A 144.93%
Sep 30, 2012 1.67 1.47 N/A 1,360.54%
Jun 30, 2012 1.83 1.54 N/A 1,883.12%
Mar 31, 2012 1.61 1.45 N/A 1,103.45%
Dec 31, 2011 1.21 1.22 N/A -81.97%
Sep 30, 2011 1.40 1.29 N/A 852.71%
Jun 30, 2011 1.37 1.28 N/A 703.13%
Mar 31, 2011 1.34 1.29 N/A 387.60%
Dec 31, 2010 1.17 1.11 N/A 540.54%
Sep 30, 2010 1.36 1.27 N/A 708.66%
Jun 30, 2010 1.38 1.30 N/A 615.38%
Mar 31, 2010 1.30 1.23 N/A 569.11%
Dec 31, 2009 1.05 1.12 N/A -625.00%
Sep 30, 2009 1.49 1.27 N/A 1,732.28%
Jun 30, 2009 1.29 1.16 N/A 1,120.69%
Mar 31, 2009 1.08 1.15 N/A -608.70%
Dec 31, 2008 1.06 1.07 N/A -93.46%
Sep 30, 2008 1.23 1.08 N/A 1,388.89%
Jun 30, 2008 1.14 1.02 N/A 1,176.47%
Mar 31, 2008 1.12 1.04 N/A 769.23%
Dec 31, 2007 1.00 0.97 N/A 309.28%
Sep 30, 2007 1.08 1.03 N/A 485.44%
Jun 30, 2007 1.12 1.06 N/A 566.04%
Mar 31, 2007 1.08 1.08 N/A 0.00%
Dec 31, 2006 0.90 0.95 N/A -526.32%
Sep 30, 2006 1.04 0.98 N/A 612.24%
Jun 30, 2006 1.05 0.94 N/A 1,170.21%
Mar 31, 2006 0.91 0.89 N/A 224.72%
Dec 31, 2005 0.75 0.76 N/A -131.58%
Sep 30, 2005 0.85 0.82 N/A 365.85%
Jun 30, 2005 0.88 0.72 N/A 2,222.22%
Mar 31, 2005 0.72 0.67 N/A 746.27%
Dec 31, 2004 0.58 0.61 N/A -491.80%
Sep 30, 2004 0.64 0.62 N/A 322.58%
Jun 30, 2004 0.62 0.60 N/A 333.33%
Mar 31, 2004 0.57 0.55 N/A 363.64%
Dec 31, 2003 0.46 0.48 N/A -416.67%
Sep 30, 2003 0.53 0.51 N/A 392.16%
Jun 30, 2003 0.49 0.46 N/A 652.17%
Mar 31, 2003 0.42 0.39 N/A 769.23%
Dec 31, 2002 0.35 0.35 N/A 0.00%
Sep 30, 2002 0.34 0.32 N/A 625.00%
Jun 30, 2002 0.38 0.35 N/A 857.14%
Mar 31, 2002 0.32 0.32 N/A 0.00%
Dec 31, 2001 0.30 0.31 N/A -322.58%
Sep 30, 2001 0.30 0.29 N/A 344.83%
Jun 30, 2001 0.30 0.28 N/A 714.29%
Mar 31, 2001 0.28 0.27 N/A 370.37%
Dec 31, 2000 0.24 0.25 N/A -400.00%
Sep 30, 2000 0.29 0.27 N/A 740.74%
Jun 30, 2000 0.28 0.27 N/A 370.37%
Mar 31, 2000 0.25 0.25 N/A 0.00%
Dec 31, 1999 0.26 0.25 N/A 400.00%
Sep 30, 1999 0.28 0.24 N/A 1,666.67%
Jun 30, 1999 0.25 0.23 N/A 869.57%
Mar 31, 1999 0.23 0.22 N/A 454.55%
Dec 31, 1998 0.23 0.21 N/A 952.38%
Sep 30, 1998 0.21 0.20 N/A 500.00%
Jun 30, 1998 0.21 0.18 N/A 1,666.67%
Mar 31, 1998 0.18 0.17 N/A 588.24%
Dec 31, 1997 0.17 0.17 N/A 0.00%
Sep 30, 1997 0.17 0.17 N/A 0.00%
Jun 30, 1997 0.18 0.18 N/A 0.00%
Mar 31, 1997 0.16 0.16 N/A 0.00%
Dec 31, 1996 0.16 0.16 N/A 0.00%
Sep 30, 1996 0.16 0.15 N/A 666.67%
Jun 30, 1996 0.16 0.15 N/A 666.67%
Mar 31, 1996 0.13 0.13 N/A 0.00%

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $11.97B $N/A $91.84B $85.96B $5.88B
2023-12-31 $10.94B $N/A $97.15B $90.92B $6.23B
2022-12-31 $7.63B $N/A $65.12B $61.46B $3.66B
2021-12-31 $7.99B $N/A $61.17B $54.47B $6.70B
2020-12-31 $6.27B $N/A $62.95B $53.54B $9.41B
2019-12-31 $6.04B $N/A $59.71B $50.03B $9.67B
2018-12-31 $6.95B $N/A $66.42B $53.92B $12.50B
2017-12-31 $3.80B $N/A $79.95B $54.71B $25.24B
2016-12-31 $3.24B $N/A $77.63B $47.75B $29.88B
2015-12-31 $4.14B $N/A $71.58B $43.37B $28.08B
2014-12-31 $3.73B $N/A $69.01B $43.23B $25.78B
2013-12-31 $3.81B $N/A $66.13B $44.03B $22.10B
2012-12-31 $3.26B $N/A $54.30B $35.24B $19.06B
2011-12-31 $6.95B $N/A $48.87B $29.84B $19.03B
2010-12-31 $3.29B $N/A $43.49B $19.54B $23.94B
2009-12-31 $2.88B $N/A $39.63B $16.96B $22.67B
2008-12-31 $1.77B $N/A $36.44B $16.06B $20.39B
2007-12-31 $2.02B $N/A $34.64B $16.77B $17.87B
2006-12-31 $1.28B $N/A $33.79B $14.82B $18.96B
2005-12-31 $1.84B $N/A $29.30B $8.85B $20.45B
2004-12-31 $1.53B $N/A $29.22B $9.52B $19.71B
2003-12-31 $837.00M $N/A $26.18B $6.72B $19.39B
2002-12-31 $1.85B $N/A $24.46B $6.17B $18.29B
2001-12-31 $689.10M $N/A $6.44B $1.23B $5.22B
2000-12-31 $226.50M $N/A $5.40B $1.09B $4.31B
1999-12-31 $130.90M $N/A $4.08B $1.05B $3.02B
1998-12-31 $201.10M $N/A $3.67B $1.11B $2.56B
1997-12-31 $239.10M $N/A $3.11B $970.90M $2.14B
1996-12-31 $169.30M $N/A $2.77B $859.30M $1.91B
1995-12-31 $66.70M $N/A $2.43B $761.00M $1.67B
1994-12-31 $211.30M $N/A $1.99B $719.80M $1.27B
1993-12-31 $128.50M $N/A $1.77B $593.50M $1.17B
1992-12-31 $92.00M $N/A $1.37B $440.60M $933.70M
1991-12-31 $146.50M $N/A $865.50M $334.40M $531.10M
1990-12-31 $35.70M $N/A $514.00M $116.00M $398.00M
1989-12-31 $39.20M $N/A $308.10M $120.00M $188.10M
1988-12-31 $20.70M $N/A $207.10M $45.20M $161.90M
1987-12-31 $105.60M $N/A $192.80M $29.30M $163.50M
1986-12-31 $57.60M $N/A $96.80M $12.80M $84.00M
1985-12-31 $66.60M $N/A $93.70M $13.10M $80.60M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 29, 2025 N/A N/A N/A N/A N/A N/A
Sep 25, 2025 N/A N/A N/A N/A N/A N/A
Sep 11, 2025 N/A N/A N/A N/A N/A N/A
Sep 04, 2025 N/A N/A N/A N/A N/A N/A
Aug 20, 2025 N/A N/A N/A N/A N/A N/A
Jun 24, 2025 N/A N/A N/A N/A N/A N/A
Jun 06, 2025 N/A N/A N/A N/A N/A N/A
Jun 05, 2025 N/A N/A N/A N/A N/A N/A
May 14, 2025 N/A N/A N/A N/A N/A N/A
May 12, 2025 N/A N/A N/A N/A N/A N/A
May 05, 2025 N/A N/A N/A N/A N/A N/A
Apr 16, 2025 N/A N/A N/A N/A N/A N/A
Apr 15, 2025 N/A N/A N/A N/A N/A N/A
Apr 11, 2025 N/A N/A N/A N/A N/A N/A
Apr 09, 2025 N/A N/A N/A N/A N/A N/A
Apr 08, 2025 N/A N/A N/A N/A N/A N/A
Feb 24, 2025 N/A N/A N/A N/A N/A N/A
Feb 21, 2025 N/A N/A N/A N/A N/A N/A
Feb 19, 2025 N/A N/A N/A N/A N/A N/A
Feb 11, 2025 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist